Real-world Biapenem vs. Meropenem in the treatment of severe community-acquired pneumonia in children: A propensity score matching analysis

OBJECTIVE: To compare the real-world efficacy and safety of Biapenem and Meropenem for treating severe community-acquired pneumonia (SCAP) in children. METHODS: We retrospectively evaluated 915 children with SCAP who were treated with Biapenem or Meropenem from August 2018 to June 2022. A 1:1 propen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Xuemei, Xu, Changjing, Zhong, Xiaoyan, Mou, Yao, Li, Jingwei, Yang, Xuping, Huang, Yilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720139/
https://www.ncbi.nlm.nih.gov/pubmed/36479282
http://dx.doi.org/10.3389/fped.2022.1047595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720139/
https://www.ncbi.nlm.nih.gov/pubmed/36479282
http://dx.doi.org/10.3389/fped.2022.1047595

Ejemplares similares